Scientists in Singapore will be allowed to withdraw stem cells from adult human tissues, aborted fetuses, and surplus embryos less than 14 years old for research purposes, according to new guidelines approved by the Central Government July 17, 2002. The cloning of... Read More
A recent report by the accounting firm, Ernst & Young, finds an increase in the amount of investment by governments in the Asia-Pacific region in biotechnology. Besides investment incentives and tax breaks, governments have begun to nurture the fledgling industry with increased... Read More
The regulatory system for medical device registration in Singapore is changing. On April 1, 2001, changes in regulations as well as a new statutory board were announced. The new agency, called the Health Sciences Authority (HSA), aims to provide a “one-stop, multi-disciplinary... Read More
The government is the largest financer of biotechnology in Singapore. It is hoped that the industry will soon meet the ranks of the country’s three leading industries — electronics, engineering, and chemical manufacturing. In October 2000, Singapore’s government designated S$1 billion (US$600... Read More
The market for medical equipment in Singapore expanded significantly in recent years. Singapore’s economic recovery accounted for much of the improvement. Medical device imports increased from US$412 million in 1999 to US$496 million in 2000 and are expected to rise further (final... Read More
Compared to the U.S. and many European countries, the biotechnology industry in Asia is embryonic. However, in recent years, several Asian countries have designated the expansion of biotechnology as crucial to their economic development. Some governments in Asia have thus begun taking... Read More
Singapore is expected to institute new requirements for medical device registration within the next few years. Currently, very few medical devices are subject to mandatory product registration in Singapore. Among those products that do require registration are radiation-emitting equipment, contact lenses and... Read More
The US Trade Development Agency (TDA) estimates that developing countries in Asia will spend over $6 billion on healthcare technology over the next five years. There are at least 25 large-scale healthcare technology projects either underway or on the drawing board in... Read More
Despite sluggish economies in some countries, Asia still represents future growth opportunities in healthcare products. Over the next 20 years, Asian healthcare markets are expected to grow at a rate two and a half times that of the West. A rising standard... Read More
Singapore, a tiny city-state with a population of only 4 million, has one of the world’s strongest economies, with GDP per capita of US$28,000, similar to that of the United States. Singapore spends approximately US$2.5 billion per year on healthcare, for an... Read More